Inherited thrombophilia in ischemic stroke and its pathogenic subtypes

Stroke

Volumn 32, Issue 8, 2001, Pages 1793-1799

  Hankey, Graeme J ^a   Eikelboom, John W ^a   Van Bockxmeer, Frank M ^b   Lofthouse, Elizabeth ^a   Staples, Nicole ^a   Baker, Ross I ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cerebral infarction; Stroke classification; Thrombophilia

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0034883626     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.8.1793     Document Type: Article

References (35)

1. Venous thrombosis: A multicausal disease
2. Leppert MF, Long GL, Hereditary thrombophilia as a model for multigenic disease
3. Genetics of coagulation disorders
4. A Scottish Hebridean antithrombin III deficient family: Twelve years on
5. Cerebral infarction in a heterozygote with variant antithrombin III
6. Free protein S deficiency in acute ischaemic stroke: A case control study
7. Free protein S spectrum in young patients with stroke
8. Inherited protein C deficiency and nonhaemorhagic arterial stroke in young adults
9. Accelerated brain infarction in hypertension complicated by hereditary heterozygous protein C deficiency
10. Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension
11. Neurological complications in children with protein C deficiency
12. Bilateral posterior cerebral infarction in a young man with a congenital deficit in protein C
13. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
14. For the Cerebral Venous Sinus Thrombosis Study Group. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions
15. Risk of stroke in young women and two prothrombotic mutations: Factor V Leiden and prothrombin gene variant (G20210A)
16. Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: A case-control study on 225 patients
17. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
18. G20210A mutation in pro-thrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
19. Blood Coagulation
20. For the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Prospective study of markers of hemostatic function with risk of ischemic stroke
21. Neurology and the blood: Haematological abnormalities in ischaemic stroke
22. Infrequency of stroke caused by specific coagulation disorders
23. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke
24. Ischemic stroke in the elderly: Role of the common factor V mutation causing resistance to activated protein C
25. Ischemic stroke due to deficiency of coagulation inhibitors: Report of 10 young adults
26. Prothrombotic states in young people with idiopathic stroke: A prospective study
27. Coagulation disorders in young adults with acute cerebral ischaemia
28. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischaemic stroke
29. Screening for the Factor-V Arg 506 Gln mutation in patients with TIA and stroke
30. Experience from a multicentre stroke register: A preliminary report
31. Mutation in blood coagulation factor V associated with resistance to activated protein C
32. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
33. Antithrombin III and procoagulant activity: Sex differences and effects of the menopause
34. Collaborative overview of randomised trials of antiplatelet therapy 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients